Table 2 Outcomes of women who responded to 2.5 mg letrozole and who did not respond to 2.5 mg letrozole
Variables | Response to 2.5 mg letrozole (n = 131) | No response to 2.5 mg letrozole (n = 83) | P-value |
|---|---|---|---|
Pregnancy rate | 85/131 (64.8%) | 26/83 (31.3%) | < 0.001 |
Live birth rate | 69/131 (52.7%) | 18/83 (21.7%) | < 0.001 |
Pregnancies per ovulating patient | 85/131 (64.9%) | 26/74 (35.1%) | < 0.001 |
Live births per ovulating patient | 69/131 (52.7%) | 18/74 (24.3%) | < 0.001 |
Pregnancies per cycle | 85/320 (26.6%) | 26/285 (7.0%) | < 0.001 |
Live births per cycle | 69/320 (21.6%) | 18/285 (6.3%) | < 0.001 |
Average cycles taken to pregnancy (mean ± SD) | 1.82 ± 0.90 | 2.77 ± 0.82 | < 0.001 |